Answers are grounded in this paper and cite their sources.
This case series study uses data from the FDA Adverse Event Reporting System to investigate a potential association between enfortumab vedotin treatment and Stevens-Johnson Syndrome and toxic epidermal necrolysis.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: